Monitoring immunogenicity of protein-based TNF antagonists
- 14 May 2015
- journal article
- letter
- Published by BMJ in Frontline Gastroenterology
- Vol. 7 (2) , 152-154
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guideFrontline Gastroenterology, 2015
- Tailoring Treatment to the Individual Patient: Drug MonitoringDigestive Diseases, 2014
- Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel DiseasesAmerican Journal of Gastroenterology, 2014
- Personalized Medicine: Theranostics (Therapeutics Diagnostics) Essential for Rational Use of Tumor Necrosis Factor-alpha Antagonists2013
- Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2012
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2012
- Differential effect of drug interference in immunogenicity assaysJournal of Immunological Methods, 2011
- Assessing Response and Loss of Response to Biological Therapies in IBDAmerican Journal of Gastroenterology, 2011
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2010
- Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodiesScandinavian Journal of Gastroenterology, 2009